New insider activity at HCA Healthcare ( (HCA) ) has taken place on February 5, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recent insider activity at HCA Healthcare shows significant share sales by top executives. CEO Samuel Hazen unloaded 42,877 shares of HCA Healthcare stock in a transaction totaling $21,483,027, signaling a major cash-out at current market levels. In a separate move, Executive Vice President and Chief Clinical Officer Michael Cuffe sold 1,500 shares of HCA Healthcare stock, generating proceeds of $747,135. These combined insider sales highlight meaningful profit-taking by HCA’s leadership team while offering a glimpse into how senior executives are managing their equity positions in the company.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Outperform.
The score is driven by strong operating performance and cash generation plus a clearly positive price trend. The biggest offset is elevated balance-sheet risk (high debt and negative equity), and guidance includes meaningful policy/reimbursement headwinds that increase execution risk despite management’s mitigation plans and enhanced shareholder returns.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
YTD Price Performance: 5.74%
Average Trading Volume: 1,223,549
Technical Sentiment Signal: Buy
Current Market Cap: $112.6B